touchINFECTIOUSDISEASES caught up with Craig Hoesley (Division of Infectious Diseases, University of Alabama School of Medicine, Birmingham, Alabama, US) to discuss the phase 1 trial investigating intrarectal dapivirine gel for HIV prevention. Part 1 of our discussion can be viewed here. His abstract entitled: ‘A randomized, double blind, placebo-controlled, phase 1 safety and pharmacokinetic study […]